Hollow Dodecahedral Nanocages for Reliable Multi-Level Differentiation of Urological Cancers through Non-Invasive Metabolic Fingerprinting
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.5c04568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Ting Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Institutes of Biomedical Sciences, Zhongshan Hospital, Fudan University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Urologic Neoplasms, Nanostructures, Metabolomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Urological cancers, including bladder cancer (BCa), prostate cancer (PCa), and renal cancer (RCa), represent the most common malignancies of the urinary system and account for a significant proportion of global cancer-related morbidity and mortality. Despite advances in imaging and pathology, achieving accurate and tiered differentiation among these entities remains clinically challenging due to overlapping symptoms, heterogeneous progression patterns, and limited noninvasive diagnostic tools. Herein, we developed hollow dodecahedral trimetallic oxide nanocages (TONCs) via a metal-organic framework (MOF)-derived synthesis strategy. Leveraging synergistic compositional and structural features, the TONCs exhibited enhanced photoresponsive behavior, thermal conductivity, and stability. As a high-performance matrix for LDI-MS, TONCs enabled the direct analysis of urine samples within seconds while minimizing background interference and improving ionization efficiency. Combined with Gradient Boosting, the approach achieved robust multiclass classification with area under the curve (AUC) values of 0.940 (training set) and 0.944 (testing set). Furthermore, nine m/z features were selected to construct a simplified yet effective urological cancer differentiation platform (UC-D9), which retained a high classification performance. Pathway analysis elucidated the underlying metabolic mechanisms associated with these malignancies. Together, this study provides a clinically translatable strategy for high-throughput metabolomic profiling, offering a promising tool for the noninvasive, accurate, and multilevel differentiation of urological cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Institutes of Biomedical Sciences, Zhongshan Hospital, Fudan University, Shanghai 200433, China.
- Department of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- School of Materials Science and Chemical Engineering, Ningbo University, Ningbo 315211, China.
- Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Department of Chemistry, Institutes of Biomedical Sciences, Fudan University, Shanghai 201399, China.
ORCID-Profile: Fangying Shi, Chunhui Deng
Förderung
- National Key Research and Development Program of China
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Zhang, T., Zhang, H., Qi, J., Jiang, S., Shi, F., & Deng, C. (2025). Hollow Dodecahedral Nanocages for Reliable Multi-Level Differentiation of Urological Cancers through Non-Invasive Metabolic Fingerprinting. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c04568
Vancouver
Zhang T, Zhang H, Qi J, Jiang S, Shi F, Deng C. Hollow Dodecahedral Nanocages for Reliable Multi-Level Differentiation of Urological Cancers through Non-Invasive Metabolic Fingerprinting. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c04568
BibTeX
@article{Zhang2025,
author = {Zhang, Ting and Zhang, Heyuhan and Qi, Jia and Jiang, Shuai and Shi, Fangying and Deng, Chunhui},
title = {Hollow Dodecahedral Nanocages for Reliable Multi-Level Differentiation of Urological Cancers through Non-Invasive Metabolic Fingerprinting},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.5c04568}
}
EUVIMED